G
Gordon T. McInnes
Researcher at University of Glasgow
Publications - 158
Citations - 22182
Gordon T. McInnes is an academic researcher from University of Glasgow. The author has contributed to research in topics: Blood pressure & Angiotensin II. The author has an hindex of 47, co-authored 158 publications receiving 21233 citations. Previous affiliations of Gordon T. McInnes include University of Cambridge & University of Oslo.
Papers
More filters
Journal ArticleDOI
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
Peter S. Sever,Björn Dahlöf,Neil R Poulter,Hans Wedel,Gareth Beevers,Mark J. Caulfield,Rory Collins,Sverre E. Kjeldsen,Arni Kristinsson,Gordon T. McInnes,Jesper Mehlsen,Markku S. Nieminen,Eoin O'Brien,Jan Östergren +13 more
TL;DR: The reductions in major cardiovascular events with atorvastatin are large, given the short follow-up time, and may have implications for future lipid-lowering guidelines.
Journal ArticleDOI
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial
Björn Dahlöf,Peter S. Sever,Neil R Poulter,Hans Wedel,D Gareth Beevers,Mark J. Caulfield,Rory Collins,Sverre E. Kjeldsen,Arni Kristinsson,Gordon T. McInnes,Jesper Mehlsen,Markku S. Nieminen,Eoin O'Brien,Jan Östergren +13 more
TL;DR: The amlodipine-based regimen prevented more major cardiovascular events and induced less diabetes than the atenolol- based regimen, and these effects might not be entirely explained by better control of blood pressure.
Proceedings ArticleDOI
2003 European society of hypertension - European Society of Cardiology guidelines for the management of arterial hypertension
Giuseppe Mancia,Enrico Agabiti Rosei,Renata Cifkova,G DeBacker,Serap Erdine,Robert Fagard,Csaba Farsang,Antony M. Heagerty,K Kawecka-Jaszcs,Wolfgang Kiowski,Sverre E. Kjeldsen,Thomas F. Lüscher,Gordon T. McInnes,Jean-Michel Mallion,Eoin O. Brien,Neil Poulter,Silvia G. Priori,Karl Heinz Rahn,Jose L. Rodicio,L. Ruilope,M. E. Safar,Jan A. Staessen,P. A. Van Zwieten,Bernard Waeber,Bryan Williams,Alberto Zanchetti,Faiez Zannad +26 more
TL;DR: The Committee has tried to avoid giving rigid rules that would constrain judgement on the management of individual patients differing in their personal, medical and cultural characteristics.
Journal ArticleDOI
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
Stevo Julius,Sverre E. Kjeldsen,Michael A. Weber,Hans R. Brunner,Steffan Ekman,Lennart Hansson,Tsushung Hua,John H. Laragh,Gordon T. McInnes,Lada Mitchell,Francis Plat,Anthony Schork,Beverly Smith,Alberto Zanchetti +13 more
TL;DR: Blood pressure was reduced by both treatments, but the effects of the amlodipine-based regimen were more pronounced, especially in the early period, which emphasise the importance of prompt blood-pressure control in hypertensive patients at high cardiovascular risk.
Journal ArticleDOI
Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004—BHS IV
Bryan Williams,Neil R Poulter,Morris J. Brown,Mark David McGregor Davis,Gordon T. McInnes,John F. Potter,Peter S. Sever,McG Thom S +7 more
TL;DR: Advice on life-style modifications for all people with high blood pressure (BP) and those with borderline or high-normal BP is provided and there are compelling indications and contraindications for specific classes of antihypertensive drugs, and these are specified.